4-(N,N-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole,
7-(1-piperazinyl)-N,N-dimethyl-4-benzofurazan sulfonamide,
DBD-PZ,
Dbd-PZ,
139332-64-2,
4-(N,N-Dimethylsulfamoyl)-7-piperazino-benzofurazan,
4-(N,N-Dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole,
4-(N,N-Dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole,
N,N-Dimethyl-7-(piperazin-1-yl)benzo[c][1,2,5]oxadiazole-4-sulfonamide,
DBD-PZ [=4-(N,N-Dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole] [for HPLC Labeling],
AC1L30M1,
SCHEMBL14778790,
CTK8B3390,
7-(1-Piperazinyl)-N,N-dimethyl-4-benzofurazan sulfonamide,
DTXSID30161012,
ZINC2556796,
ANW-42452,
MFCD00191375,
AKOS030530734,
RTR-005162,
TR-005162,
J-007265,
N,N-Dimethyl-7-piperazino-4-benzofurazansulfonamide,
4-(N,N-Dimethylaminosulfonyl)-7-piperazinobenzofurazan,
I14-63595,
4-Benzofurazansulfonamide, N,N-dimethyl-7-(1-piperazinyl)-,
N,N-dimethyl-7-piperazin-1-yl-2,1,3-benzoxadiazole-4-sulfonamide,
4-(N,N-Dimethylsulfamoyl)-7-piperazino-benzofurazan, for fluorescence, >=99.0%,
C12H17N5O3S,
C12-H17-N5-O3-S,
CID132229,
A5555,